Clene Inc. (NASDAQ:CLNNW) Sees Large Growth in Short Interest

Clene Inc. (NASDAQ:CLNNW) saw a significant growth in short interest in the month of December. As of December 15th, there was short interest totaling 3,235 shares, a growth of 39.3% from the November 30th total of 2,323 shares. Based on an average trading volume of 29,217 shares, the days-to-cover ratio is currently 0.1 days. Based on an average trading volume of 29,217 shares, the days-to-cover ratio is currently 0.1 days.

Clene Trading Down 28.0%

NASDAQ:CLNNW opened at $0.00 on Tuesday. The firm’s fifty day simple moving average is $0.01 and its 200 day simple moving average is $0.02. Clene has a twelve month low of $0.00 and a twelve month high of $0.05.

Clene Company Profile

Clene Nanomedicine, Inc is a clinical-stage biopharmaceutical company dedicated to the development of novel nanocatalytic compounds designed to address degenerative and neurodegenerative disorders. Headquartered in Salt Lake City, Utah, Clene leverages proprietary gold nanocrystal technology to create therapies that enhance cellular bioenergetics and mitigate oxidative stress—mechanisms believed to play critical roles in slowing or reversing disease progression.

The company’s lead investigational product, CNM-Au8®, is an orally administered, clean-surfaced gold nanocrystal suspension engineered to catalytically support neuron health.